Clinical Trial Update: Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms. [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of BYON4413 in relapsed/refractory acute myeloid leukemia and myelodysplastic neoplasms reports safety, pharmacokinetics, and prelimina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• BYON4413

Snippet

Sponsor: Byondis B.V. | Conditions: Relapsed / Refractory AML, Relapsed / Refractory MDS | Phase 1 | Status: ACTIVE_NOT_RECRUITING